文献速递医学教育与科研方法流行病学与生物统计

患者研究伙伴在核心结局集开发中的角色:一项系统综述

Patient research partners in core outcome set development: a systematic review.
PubMed 文献 · J Clin Epidemiol · 2025-08-08

该系统综述检索了2023年9月15日前的Medline、Embase和Web of Science,纳入94篇文章描述的64项核心结局集(COS)开发研究,梳理患者研究伙伴(PRP)的角色与参与策略。研究发现PRP术语、角色和参与方式存在差异,最频繁的任务是指导流程(70%)和设计问卷(64%),并建议研究者参照COMET手册等既定指南以统一PRP术语和定义。

要点

  • 64项COS开发研究中,PRP最常承担的任务是指导流程(70%)和设计问卷(64%)。
  • 41项(64%)研究在涉及患者参与设计时引用了COMET手册。
  • 69%的研究纳入了PRP但未明确使用该称谓,31%的研究还将PRP参与德尔菲研究、访谈等其他活动。

核心结论

  • 该系统综述发现现有COS研究中PRP的术语、角色和参与方式存在差异,建议研究者参照COMET手册等既定指南以统一PRP术语和定义,这些发现为未来PRP参与奠定基础,旨在平衡有意义参与与COS开发可行性。

研究设计与样本

  • 系统综述,检索Medline、Embase和Web of Science(2023年9月15日),纳入用英文发表、涉及PRP的进行中或已完成的COS开发研究,共纳入94篇文章描述64项COS开发研究,并应用COS-Standards for Development评估COS质量。

主要发现

  • 检索识别2261条唯一记录,最终纳入94篇文章描述64项COS开发研究,最早发表于2014年。
  • 41项(64%)研究在设计患者参与COS开发时引用了COMET手册,引用与未引用COMET手册的研究中PRP占研究团队成员的比例均为17%。
  • 69%的研究纳入了PRP但未明确使用该称谓,31%的研究还将PRP参与德尔菲研究和访谈等其他活动。
  • 研究描述的PRP任务多样,最频繁的是指导流程(70%)和设计问卷(64%)。

关键数值与推荐

  • 应用COS-Standards for Development评估COS质量;PRP占研究团队成员比例在引用COMET手册的研究中为17%,未引用者也为17%。

临床怎么用

  • 作者建议研究者参照COMET手册等既定指南,以统一PRP术语和定义,并帮助确定在COS开发全过程中让患者作为伙伴参与的合适途径。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: A core outcome set (COS) is a minimal set of outcomes that clinical trials in a specific health or health-care area should report. Patient research partners (PRPs) should engage in all stages of COS development (coleading and codeveloping the COS). PRPs contribute the lived experience of a condition, and this perspective can improve the quality and uptake of COSs. However, there is variability in PRP responsibilities, which can impede meaningful involvement in COS development. The study aims to systematically review the roles of PRPs in COS development studies and compare their involvement strategies with available guidance. METHODS: We included ongoing and completed COS development studies published in English that involved PRPs. We searched Medline, Embase, and Web of Science on September 15, 2023. We applied COS-Standards for Development to assess the quality of the COS. We extracted, tabulated, and described details of the COS development studies. RESULTS: Our searches identified 2261 unique records, of which we included 94 articles describing 64 COS development studies. The earliest publication was in 2014. Forty-one (64%) studies cited the Core Outcome Measures in Effectiveness Trials (COMET) Handbook when designing patient engagement for COS development. Among research team members, the proportion who was PRPs was similar in studies that cited the COMET Handbook (17%) and in those that did not (17%). Sixty-nine percent of studies included PRPs but did not specifically include this nomenclature, and 31% also involved PRPs in other activities, such as Delphi studies and interviews. The studies described various PRP tasks, the most frequent of which were guiding the process (70%) and designing questionnaires (64%). CONCLUSION: This systematic review identified variations in PRP terminology, roles, and engagement across existing COS studies. We recommend that researchers refer to established guidelines, such as the COMET Handbook, for consistent PRP terminology and definitions. Such guidance can also help identify appropriate avenues for engaging patients as partners throughout the COS development process. These findings lay the foundation for future PRP involvement, aiming to balance meaningful engagement with feasibility in COS development.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Huang NS, Saldanha IJ, Ervin AM, et al. Patient research partners in core outcome set development: a systematic review. J Clin Epidemiol. 2025. PMID: 40782978. doi:10.1016/j.jclinepi.2025.111926

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。